Organization
Grupo Español de Investigación en Sarcomas
11 clinical trials
Clinical trial
Phase Ib/II Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination With Radiotherapy in Soft Tissue Sarcomas and Other Solid TumorsStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Phase I/II Randomized Clinical Trial of Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and OsteosarcomaStatus: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Phase II Multicenter Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Phase I/II Randomized Trial of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue SarcomasStatus: Recruiting, Estimated PCD: 2025-06-20
Clinical trial
Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma PatientsStatus: Recruiting, Estimated PCD: 2028-06-01
Clinical trial
A Multicenter, Phase Ib/II Trial of Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GISTs)Status: Active (not recruiting), Estimated PCD: 2023-04-16
Clinical trial
Phase II, Single Arm, Non-randomized and Multicenter Clinical Trial of Regorafenib as a Single Agent in the First-line Setting for Patients With Metastatic and/or Unresectable KIT/PDGFR Wild Type GISTStatus: Completed, Estimated PCD: 2021-08-31
Clinical trial
Phase II Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasStatus: Recruiting, Estimated PCD: 2024-07-28
Clinical trial
Phase I Clinical Trial of Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma PatientsStatus: Active (not recruiting), Estimated PCD: 2021-02-17
Clinical trial
A Phase II Open-Label Trial of Pazopanib Administered as a Single Agent in Patients With Unresectable or Metastatic Solitary Fibrous Tumor (SFT) and Extraskeletal Myxoid Chondrosarcoma (EMC)Status: Completed, Estimated PCD: 2019-12-01
Clinical trial
Phase I-II Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasStatus: Recruiting, Estimated PCD: 2025-06-30